TWOCELLS twocells.com


TWOCELLS is a regenerative medicine & stem cell company focused on the research, development, manufacture, and sales of therapeutic genes, cells, drugs, diagnostic agents, chemical reagent, and medical materials. In addition, the company engages in the research and development of medical appliances and medical instruments, genes, diagnosis methods, disease treatments and cell culture systems, and computer software systems related to regenerative medicine.

TWOCELLS is a regenerative medicine & stem cell company focused on the research, development, manufacture, and sales of therapeutic genes, cells, drugs, diagnostic agents, chemical reagent, and medical materials. In addition, the company engages in t...Show all

Company (Alive / Active)

Phone: +81 082-250-3138

Fax:

Hiroshima Sangyou Bunka Center Bldg, 11F
16-35, Hijiyamahonmachi, Minami-ku
Hiroshima, 732-0816
Japan

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
TWOCELLS $0M May 15, 2017
See all 4 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related TWOCELLS Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Cellect Biotechnology

Kfar Saba, Israel
IPO / Went publicCellect is an emerging biotechnology company that is developing a novel technology platform known as Powered by Cellect that functionally selects stem cells from a mixed population of cells in order to improve the safety and efficacy of regenerative medicine stem cell therapies.Login to see details

Cynata Therapeutics

Carlton, Victoria, Australia
IPO / Went publicCynata Therapeutics is an Australian stem cell and regenerative medicine company that is developing a therapeutic stem cell platform technology, Cymerus. The proprietary Cymerus technology seeks to address a critical shortcoming in existing methods of production of mesenchymal stem cells (MSCs) for therapeutic use, which is the ability to achieve economic manufacture at commercial scale. Cymerus does so through the production of a particular type of MSC precursor, called a mesenchymoangioblast (...Show allLogin to see details
See all 4 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)